首页> 外国专利> Preparations of Combination of aspirin for the primary prevention of cardiovascular diseases

Preparations of Combination of aspirin for the primary prevention of cardiovascular diseases

机译:阿司匹林联合用于心血管疾病一级预防的制剂

摘要

Refers to a combination containing ACETYLSALICYLIC ACID: (a) and (b) an HMG CoA reductase inhibitor Selected simbastatina, lovastatin, pravastatin, atorvastatin, fluvastatin, pitavastatin.The combination can also include a substance or a diuretic antihypertensive selected as an angiotensin II antagonist nifedipine, amlodipine, enalapril, ramipril, lisinopril and Hydrochlorothiazide, losartan, candesartan, among others.The combination can contain 50 mg to 350 mg ACETYLSALICYLIC ACID, 5mg to 80mg of atorvastatin, simvastatin or lovastatin as the Third Component and Amlodipine in doses of 2.5 to 20 mg enalapril 5mg to 40mg, lisinopirl 5mg to 40mg, among others. The combination is useful for the primary prevention of cardiovascular diseases
机译:指含有乙酰水杨酸的组合:(a)和(b)HMG CoA还原酶抑制剂选定的辛巴他汀,洛伐他汀,普伐他汀,阿托伐他汀,氟伐他汀,匹伐他汀(也包括被选为血管紧张素II拮抗剂的物质或利尿降压药)硝苯地平,氨氯地平,依那普利,雷米普利,赖诺普利和氢氯噻嗪,氯沙坦,坎地沙坦等;该组合可包含50 mg至350 mg乙酰水杨酸,5mg至80mg阿托伐他汀,辛伐他汀或洛伐他汀为第三剂量成分和2.5%阿莫洛地到20 mg依那普利5mg至40mg,赖诺吡咯5mg至40mg等。该组合可用于一级预防心血管疾病

著录项

  • 公开/公告号PE10622004A1

    专利类型

  • 公开/公告日2005-02-25

    原文格式PDF

  • 申请/专利权人 BAYER HEALTHCARE AG;

    申请/专利号PE20040000258

  • 发明设计人 ELMAHDI KHAIRY;WAGENER GILBERT;

    申请日2004-03-10

  • 分类号A61K45/06;A61K31/22;A61K31/366;A61K31/40;A61K31/405;A61K31/47;A61K31/505;A61K31/616;

  • 国家 PE

  • 入库时间 2022-08-21 22:16:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号